Inpatients’ willingness to accept antibiotic intravenous-to-oral switch therapy and its influencing factors: a qualitative study based on the Health Belief Model Authors: Yinqiu Deng, Yi Chen, Qiuyan Chen, Hongliang Zhang, Fuli Qin, Xiaomei Li, Xian Chen, Weiying Meng, Wen Gao, Jun Luo, Kunxuan Wei Published: 2026 ABSTRACT AbstractBackgroundAntimicrobial stewardship emphasizes the timely transition from intravenous to oral antibiotic therapy to reduce the risk of catheter-associated infections and shorten hospital stays. However, the overuse of intravenous antibiotics remains a significant issue in China. Understanding the factors that influence patients’ willingness to accept intravenous-to-oral switch (IVOS) therapy from their perspective is essential. This study aims to explore inpatients’ willingness to accept IVOS therapy and its potential influencing factors, based on the Health Belief Model (HBM), providing evidence for the development of more effective intervention strategies.MethodsBetween June and July 2025, a qualitative study guided by the HBM was conducted at a tertiary hospital in China. Fifteen inpatients receiving antibiotic therapy from five wards with high rates of intravenous antibiotic use were purposively selected for semi-structured interviews. Data were thematically analyzed and reported in accordance with the COREQ guidelines.ResultsThe study identified two themes and nine subthemes: (1) motivators to accept IVOS therapy (perceived benefits, high perceived severity, concerns about infusion safety, and action cues), (2) barriers to accept IVOS therapy (concerns about oral antibiotic effectiveness, low perceived susceptibility, low perceived severity, the “anti-inflammatory drug” label, and self-efficacy).ConclusionThis study indicates that patients lack sufficient awareness of the efficacy of oral antibiotics and the severity of antimicrobial resistance. Targeted interventions, particularly public education initiatives, can improve patient understanding of these issues, encourage more informed therapy decisions, and potentially increase acceptance of IVOS therapy.Supplementary InformationThe online version contains supplementary material available at 10.1186/s12879-026-13703-x.Keywords: Antibiotics, Intravenous, Oral, Qualitative study, Patient perception, Health belief model Introduction The rational use of antibiotics is a key issue in global public health. However, the widespread and often irrational use of antibiotics, particularly in developing countries, has significantly contributed to the rise and spread of antimicrobial resistance (AMR) [1–3]. This problem hinders infection control, increases illness and death rates, and raises healthcare costs. Without effective action, the World Health Organization (WHO) predicts that AMR could lead to as many as 10 million deaths annually by 2050 [4]. Optimizing antibiotic treatment pathways is a central focus of antimicrobial stewardship (AMS) in combating AMR [5]. As an important part of AMS strategy, Intravenous-to-Oral Switch (IVOS) therapy can reduce dependence on intravenous (IV) catheters, shorten hospital stays, and alleviate AMR pressure, all while maintaining therapeutic efficacy. This approach is recommended in clinical guidelines and supported by policies in several developed countries [6–8]. IVOS therapy refers to the timely transition from IV to oral therapy when the patient’s condition is stable, gastrointestinal function is good, and the antibiotics used have high bioavailability [9]. According to multiple surveys, the rate of IV antibiotic use in some Chinese hospitals is as high as 86%-93% [10, 11]. This reflects the gap between antibiotic use and evidence-based treatment guidelines. It also highlights the problem of overuse in IV therapy. In cases of mild to moderate infection severity with well-functioning gastrointestinal tracts, continuing IV therapy is often unnecessary. It may lead to clinical and management issues, such as catheter-related infections, a higher risk of adverse reactions, increased healthcare costs, and greater nursing workload [12–14]. Data from the National Drug Adverse Reaction Monitoring System show that in 2024, IV injections accounted for 91.0% of reported injection-related adverse events [15]. Despite the abundance of evidence-based data supporting the advantages of oral therapy, the implementation of IVOS remains quite limited in practice. Progress has been slow due to the lack of standardized clinical pathways and persistent patient beliefs that IV therapy is superior to oral therapy. These perceptions have reduced healthcare providers’ enthusiasm for implementing IVOS, hindering communication and acting as a key barrier to its wider adoption. Previous studies have mainly focused on healthcare providers’ knowledge of IVOS therapy and the barriers to its implementation [16–18]. In contrast, research into patients’ perspectives is limited, especially in settings where IV therapy is widely used. It is essential to understand patients’ views on IVOS, their willingness to accept it, and the factors that influence their decisions. Developed by psychologist I.M. Rosenstock in the 1950s, the Health Belief Model (HBM) is a widely used framework in health psychology [19]. The HBM includes perceived susceptibility, perceived severity, perceived benefits, perceived barriers, self-efficacy, and cues to action. It helps explain and predict individual health behaviors and has been widely applied to chronic disease management, vaccination programs, and other areas [20, 21]. The HBM is particularly valuable for this study, as it helps explain why patients may adhere to or resist IVOS therapy based on their personal beliefs. In China’s complex healthcare context, this research is important for identifying the barriers and facilitators influencing the acceptance of IVOS therapy. These insights may ultimately help improve patient acceptance and inform more effective intervention strategies in future research. In this study, for the first time in China, semi-structured, qualitative interviews guided by the HBM were conducted with inpatients. The aim was to explore inpatients’ knowledge of IVOS therapy, assess their willingness to accept it, and identify factors influencing their decisions. Method Study setting and design This study was conducted at the First Affiliated Hospital of Guangxi Medical University, a major tertiary hospital in Guangxi, China, directly affiliated with Guangxi Medical University. It has 46 clinical departments, 72 wards, and 2,750 beds, and serves about 3.26 million outpatients and emergency visits, as well as 150,000 inpatients annually. In this setting, we used a qualitative descriptive design to explore inpatients’ willingness to accept IVOS antibiotic therapy and the factors influencing their decisions. Qualitative descriptive is considered the most appropriate method for obtaining information that can inform the development of policies or interventions, making it ideal for this study [22]. The study adhered to the Consolidated Criteria for Reporting Qualitative Research (COREQ) guidelines (see Additional file 1) [23]. Sample and recruitment Between June and July 2025, eligible inpatients were recruited from five clinical wards with high rates of IV antibiotic use through purposive sampling [24]. The wards were selected based on 2024 hospital-wide data on IV antibiotic usage. These wards had an average annual IV antibiotic use rate of about 81%, significantly higher than the hospital’s overall average of around 45%. The selected wards include Otolaryngology and Head and Neck Surgery, Orthopedic Surgery, Gynecology, Cardiac Surgery, and Trauma and Orthopedic Surgery. Patients in the selected wards were invited to participate in semi-structured, face-to-face interviews. A total of 15 patients were enrolled, and all completed the interviews, which lasted approximately 30–45 min each, with no dropouts. Each participant received a 50 RMB gift card as compensation for their time. Data collection Interviews followed a semi-structured guide based on the HBM framework. The guide included open-ended questions and focused on patients’ perceptions of IV versus oral antibiotics, their acceptance of IVOS therapy, and key factors that may influence their decision-making. The interview guide was revised based on the results of a pilot test conducted prior to the formal interviews to ensure its content validity (see Additional file 2 for the full guide). All interviews were conducted in Chinese by the researcher (DYQ) and recorded by another researcher (CY). Written informed consent was obtained from all participants prior to the interviews. The entire interview process was audio-recorded. Interviews took place in a quiet ward office, providing a natural and undisturbed environment. The audio recordings were transcribed verbatim in Chinese and subsequently translated into English for analysis and reporting. To ensure translation accuracy, the translated transcripts were carefully reviewed by researchers proficient in both Chinese and English. Data saturation was reached after the thirteenth interview, as no new themes or subthemes emerged in the subsequent two interviews. A total of 15 in-depth semi-structured interviews were conducted. Given the repetition of themes following the thirteenth interview, we concluded that further data collection was unlikely to yield new insights, and thus confirmed that the dataset had reached saturation [25]. Analysis All participants were assigned identifiers from P1 to P15. One researcher (DYQ) verbatim transcribed the audio recordings verbatim within 24 h of each interview, and two other researchers (CY and WKX) reviewed the transcripts. The interview transcripts were analyzed using thematic content analysis in NVivo 12. The HBM served as the guiding framework for the coding process. We employed a deductive approach, using the predefined constructs within the HBM to guide the generation of initial codes. In addition, we utilized an inductive approach to ensure that emerging themes not explicitly covered by the HBM framework were captured. Based on the HBM constructs and factors identified through induction, we categorized the initial coding into themes and subthemes. Results Description of participants This study included 15 inpatients (6 males and 9 females), aged 18–60 years (mean ± SD: 36.40 ± 11.69 years). The sociodemographic characteristics of the participants are summarized in Table 1. Data analysis identified two themes and nine sub-themes. Table 1Socio-demographic characteristics of study participantsNumberGederAgeEducational levelP1F45Master’s degreeP2M18High schoolP3F21Bachelor’s degreeP4M33Bachelor’s degreeP5M40Associate degreeP6M32Associate degreeP7F41Associate degreeP8F36Bachelor’s degreeP9F54Middle schoolP10M60Primary schoolP11F36Middle schoolP12F24Associate degreeP13F43Bachelor’s degreeP14M38Bachelor’s degreeP15F25Bachelor’s degreeaM, male; F, female Socio-demographic characteristics of study participants aM, male; F, female Overall acceptance willingness All participants expressed a willingness to accept the IVOS therapy regimen recommended by their physicians. However, this willingness was often conditional. For instance, several participants mentioned that their decision to accept IVOS therapy was based on trust in their physicians. As one participant noted (P10), “I trust my doctor. If he tells me to take medicine, I will take it.” Additionally, many patients also highlighted the convenience of oral therapy as a key factor in their acceptance, with one participant stating (P12), “I prefer oral medication because it’s easier and more convenient.” Thematic analysis based on HBM constructs Based on the HBM, this study identified several factors influencing inpatients’ willingness to accept antibiotic IVOS therapy. Figure 1 summarizes the factors promoting and inhibiting patients’ willingness to accept antibiotic IVOS therapy in this study. These factors are further discussed within each HBM construct. Factors affecting patients’ acceptance of IVOS based on HBM Theme 1: Motivators to accept IVOS therapy Perceived benefits Most participants (n = 8) preferred oral therapy due to its convenience, less pain, and manageable side effects. Many also viewed oral medication as a sign of improvement in their condition. This choice aligns with the needs and psychological expectations of most patients. Switching from injections to oral medication means my condition has improved slightly. Everyone says that if you can take oral medication, you should try to avoid injections. I find injections quite uncomfortable. (P2) I prefer oral medication. I find it more convenient, and some people are afraid of needles and might faint from the pain. Oral medication also has higher public acceptance. (P6) Oral medication is more convenient and caters to people’s desire for speed these days. (P8) High perceived severity Some participants (n = 6) expressed concerns about AMR, particularly worried that the excessive or inappropriate use of antibiotics could make future treatments ineffective. There is definitely a concern about AMR; if it becomes widespread, there will be no effective medicines left. (P12) Yes, I would worry that if I use too much of that medicine, there won’t be any left, and it won’t work. (P13) Concerns about infusion safety Some participants expressed concerns about the IV infusion process, particularly regarding potential side effects and safety issues. They worried it could trigger severe reactions, such as allergies or shock. I’m worried about the potential damage that the side effects might cause to my body. I’m particularly worried about injections because they can cause symptoms such as shock and allergic reactions. (P3) I had an experience once where my hand swelled up after I received an injection. You generally don’t get such a strong reaction with oral medication. I’m a bit concerned about the safety of injections. (P4) Cues for action Participants generally viewed national policies and healthcare professionals as their most trusted sources of treatment information. Most adhered to prescribed antimicrobial regimens during hospitalization and did not proactively raise concerns or question treatment plans. This was due to their perception of lacking relevant expertise and their trust that physicians would choose the appropriate medications based on their condition. I believe their primary responsibility is to save lives, so I won’t question anything as long as they explain the medication to me. (P1) Those who come to the hospital certainly listen to the doctors. As laypeople, we don’t fully understand, but I can accept it if they decide on a medicine or an injection. (P7) I’d probably choose oral medication first. The government encourages avoiding IV drips whenever possible, so when our organs can metabolize pills normally, we’ll definitely prioritize taking them. (P14) Theme 2: Barriers to accepting IVOS therapy Concerns about oral antibiotic effectiveness Most participants (n = 10) believed that IV infusions took effect more quickly than oral medications. Injections take effect faster because they deliver the medication directly into the bloodstream, whereas oral medications are definitely less effective. (P3) Injections probably work more directly, while oral medications take longer to take effect. (P11) Additionally, some participants associated hospitalization with receiving IV fluids, viewing it as a more formal and effective treatment. I’m already in the hospital, so why do I still need to take pills? I think injections are better because they save time. (P4) Low perceived susceptibility Most participants (n = 10) reported being in good physical health and avoiding environments with infection risks. They generally perceived their risk of infection as low, leading them to believe that excessive concern about antibiotic treatment was unnecessary. This attitude may affect their acceptance of IVOS therapy, as they do not consider optimizing treatment regimens to reduce potential risks necessary. It’s not easy, because I’m generally in pretty good health. I try to avoid places where bacterial or viral infections are common. (P11) I don’t think I’m at risk of infection because I believe my immune system is strong. (P12) Low perceived severity More than half of the participants reported never having heard of AMR, and most were optimistic about the risks of AMR, believing that medical advances would provide alternative solutions. As a result, they lacked a realistic understanding of AMR’s severe consequences. I’m not worried because medicine will definitely evolve and be replaced by other medicines. (P4) What’s there to worry about? I’ve never even heard of it. (P11) The “anti-inflammatory drug” label Notably, many participants (n = 8) equated antibiotics like cephalosporins and amoxicillin with “anti-inflammatory drugs” and viewed them as routine treatments for common illnesses, such as the common cold. This misconception may lead patients to underestimate the severity of infections and neglect proper antimicrobial therapy and necessary treatment adjustments during their care. Both cephalosporin and amoxicillin are also anti-inflammatory drugs. They are commonly prescribed at pharmacies for colds and coughs. (P9) Is that an anti-inflammatory drug, amoxicillin? Isn’t the general term for antibiotics “anti-inflammatory drugs”? That’s how I understand it. (P14) Self-efficacy Some participants lack confidence in oral therapy, believing they cannot take the medication correctly or worrying about missing doses, and thus prefer to rely on IV infusions. I’m afraid I might forget to take oral medication or get the dosage wrong, which could affect my recovery. Injections are more reliable. (P9) Discussion To our knowledge, this study is the first qualitative study to explore inpatients’ willingness to accept antibiotics IVOS therapy and its influencing factors using the HBM model. The findings identified several facilitators and barriers influencing patients’ acceptance of IVOS therapy and provided insight into the cognitive and behavioral processes underlying their treatment decisions. Overall, although patients consider various factors when choosing a route of administration, most participants indicated that they would follow their physician’s recommendation. Comparison with existing studies In HBM, cues for action are important external triggers that prompt individuals to engage in healthy behaviors. In this study, physicians’ recommendations served as a key cue influencing patients’ treatment decisions. When patients are uncertain about the efficacy or safety of oral antibiotics, they tend to rely on their physician’s professional advice. Similar findings were reported in a previous qualitative study, which also emphasized the important role of healthcare providers’ recommendations in influencing health-related behaviors [26]. This finding highlights the important role of physicians in promoting IVOS therapy. Clear explanations and effective doctor–patient communication may help reduce concerns about treatment changes and improve acceptance of oral therapy. It is worth noting that our findings differ somewhat from previous studies. Research conducted in England and Suzhou, China, reported that physicians generally expressed concern that patients believed IV therapy was superior to oral therapy, and were therefore worried about patient resistance or complaints when administering IVOS therapy [16, 17]. However, in this study, although some patients believed IV therapy might be “stronger” or more effective, they tended to trust their physicians’ professional judgment and accept treatment adjustments. This difference may be related to variations in healthcare environments and doctor–patient relationships. In settings with limited healthcare resources, patients may rely more strongly on their physicians’ recommendations. Previous studies have also shown that healthcare access, health literacy, and trust in physicians influence patients’ treatment decisions [27, 28]. Additionally, the higher education levels of many participants in our study might have further facilitated their trust in medical professionals and their acceptance of IVOS therapy, as educated patients are typically more receptive to medical advice [29]. Perceived benefits were another important factor promoting acceptance of IVOS therapy. According to the HBM, individuals weigh potential benefits against risks when making health-related decisions [30, 31]. In this study, most participants believed that oral antibiotics were more convenient, less painful, and safer than IV therapy. As a result, they preferred oral therapy when their condition allowed. Previous studies have similarly reported that oral therapy improves comfort and convenience, which can increase patient acceptance [32–34]. Therefore, clearly explaining the benefits of oral therapy may help patients better understand and accept IVOS strategies. Perceived severity also influenced patients’ attitudes toward IVOS therapy. More than half of the participants had never heard of AMR or underestimated its potential risks. This finding is consistent with public surveys conducted by the WHO in multiple countries [35]. When patients recognize the seriousness of AMR, they may be more likely to understand the importance of appropriate antibiotic use and accept recommended treatment adjustments. In contrast, patients who underestimate the risks of AMR may lack motivation to change their treatment preferences, which may hinder the implementation of IVOS therapy. This is consistent with the hypothesis in HBM that patients’ perceptions of the severity of AMR influence their acceptance of the rationality of antimicrobial treatment [36]. At the same time, misconceptions about antibiotics were common among participants. Similar to previous studies, some people had difficulty distinguishing antibiotics from other medications and believed they could treat viral infections or the common cold [37]. In addition, antibiotics are still widely referred to as “anti-inflammatory drugs” in many countries and regions [38, 39]. This study found that over half of the participants used this term to describe antibiotics such as cephalosporins and amoxicillin. This misunderstanding may lead patients to underestimate the complexity of infectious diseases and the importance of appropriate antibiotic use, potentially increasing the risk of misuse [40]. Regarding perceived susceptibility, most participants believed they were generally healthy and perceived a low personal risk of infection or AMR. According to the HBM, individuals are less likely to adopt protective behaviors when they perceive a health threat as irrelevant to themselves [41]. As a result, patients with low perceived susceptibility may pay less attention to the importance of appropriate antimicrobial therapy, which may influence their acceptance of treatment adjustments. Finally, self-efficacy was identified as an important barrier to IVOS therapy. Some patients lack confidence in oral therapy, worrying that they may not take their medication correctly or miss doses. Consequently, they prefer IV therapy administered in a hospital setting. Previous studies have also shown that patients with low self-efficacy are more likely to misuse antibiotics [42, 43]. Strengthening medication guidance and patient education may help improve patients’ self-management skills and increase their confidence in oral therapy, thereby promoting acceptance of IVOS therapy. Implications for clinical practice Based on the results of the HBM analysis, this study offers several key insights for clinical practice. First, physicians’ recommendations, as important cues for action, play a central role in influencing patients’ acceptance of IVOS. Given the high level of trust patients place in clinicians, clinicians should proactively recommend IVOS when appropriate and clearly explain its safety and efficacy. Second, concerns regarding the effectiveness of oral antibiotics remain a major barrier. This misconception must be addressed through targeted patient education, emphasizing the equivalence of oral and IV administration in specific clinical settings. Finally, enhancing patients’ self-efficacy and perceived threat is essential. By providing medication guidance and engaging in communication, we can boost their confidence in switching treatments and reinforce their understanding of the severity of the disease and the risks associated with inappropriate IV therapy, thereby promoting acceptance of IVOS. Previous studies have shown that by heightening individuals’ perception of the risks associated with AMR and emphasizing the potential benefits of appropriate antibiotic use, it is possible to more effectively promote behavioral change [44]. This study was conducted in a ward with a high rate of IV antibiotic use. The findings may also apply to other healthcare settings where IV antibiotic administration remains common and clinical decision-making is primarily driven by clinicians. Across different countries and health systems, patients’ acceptance of IVOS is likely influenced by shared factors, including trust in physicians, concerns about the effectiveness of oral antibiotics, and levels of health literacy. The identified motivators and barriers may provide useful insights for designing targeted educational and communication strategies in similar contexts. Advantages and limitations This study is the first to apply the HBM to investigate patients’ perceptions of and willingness to accept IVOS therapy. By applying a thematic analysis approach guided by the HBM framework, we were able to systematically explore patients’ experiences and perceptions and identify key motivators and barriers influencing acceptance of IVOS. Our findings have practical implications for the development of patient-centered interventions. However, this study has some limitations that should be acknowledged. First, the study sample was recruited from a single center and the majority of participants had higher levels of education. Therefore, caution should be exercised when generalizing the findings to different populations or healthcare settings. Future research should include a more diverse sample to improve the generalizability of the findings. Second, although the interviews were conducted in Chinese and the results were reported in English, translation may have introduced minor semantic differences despite careful review by the research team. Conclusion This study is the first to explore inpatients’ willingness to accept antibiotic IVOS therapy and the factors influencing it in China. Research findings indicate that patients’ treatment decisions are influenced by several factors, particularly physician recommendations, perceived benefits, perceived severity, and self-efficacy. These results provide a basis for developing targeted health education and intervention strategies. Future interventions should focus on strengthening physician–patient communication, improving patients’ understanding of the benefits of IVOS therapy, increasing awareness of the risks and severity of AMR, and enhancing patients’ self-efficacy. Supplementary Information Below is the link to the electronic supplementary material. Supplementary Material 1: Additional file 1. COREQ (Consolidated Criteria for Reporting Qualitative Research) checklist. Supplementary Material 2: Additional file 2. Interview guide. Acknowledgements The authors acknowledge the support of all the interviewees who participated in the study. Abbreviations Intravenous-to-oral switch Antimicrobial resistance Antimicrobial stewardship Intravenous Health Belief Model Consolidated Criteria for Reporting Qualitative Research Author contributions DYQ and CY contributed equally to this work and share first authorship. DYQ: Writing -Original Draft, Writing -Review & Editing. CY: Formal Analysis, Writing-Review & Editing. CQY, ZHL, and MWY: Methodology, Investigation. QFL, CX, and LXM: Investigation, Data Curation, Resources. GW: Writing-Review & Editing. LJ and WKX: Supervision, Writing-Review & Editing. All authors read and approved the final manuscript. Funding This work was supported by the Special Fund Grant for Clinical Discipline Construction of Guangxi Medical University (grant number: GXMULJZ202414) and the Innovation Management Cultivation Program at the First Affiliated Hospital of Guangxi Medical University (grant number: YYZS2024034). Data availability The data generated from this study are not publicly available, as confidentiality of the participants has to be maintained, but are available from the corresponding author with permission from the Ethics Committee of the First Affiliated Hospital of Guangxi Medical University. Declarations Ethical approval This study was conducted in accordance with the principles of the Declaration of Helsinki. The experimental protocol was approved by the Ethics Committee of the First Affiliated Hospital of Guangxi Medical University (approval number: 2025-E0498). Written informed consent was obtained from all study participants. Consent for publication Not applicable. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Yi Chen contributed equally to this study and should be considered co-first authors. Contributor Information Jun Luo, Email: junluogxmufah@gmail.com. Kunxuan Wei, Email: kunxuanweigxmufah@gmail.com. References Associated Data Supplementary Materials Supplementary Material 1: Additional file 1. COREQ (Consolidated Criteria for Reporting Qualitative Research) checklist. Supplementary Material 2: Additional file 2. Interview guide. Data Availability Statement The data generated from this study are not publicly available, as confidentiality of the participants has to be maintained, but are available from the corresponding author with permission from the Ethics Committee of the First Affiliated Hospital of Guangxi Medical University.